Sign in to view content

Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

Dante Joseph Pieramici, MD

Video
Published 2017

Related

What Is the Clinical Significance of Improving Diabetic Retinopathy for Vision Outcomes? A Meta-Analysis of 5 Ranibizumab Trials
Sophie Jane Bakri, MD
Annual Meeting Talks
2021
Laser Photocoagulation for Type 2 Retinopathy of Prematurity (ROP) or Less: When and Why?
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2020
20+ Years of The DRCR Network: What We Have Learned About Diabetic Retinopathy
John W. Kitchens, MD
Updates from the Field
2025

Category: Diabetic Retinopathy

See more